Royal DSM to improve the health and environmental impact of animals has acquired remaining stake of Midori USA, Inc. for USD 63 million. Boston based Midori, is a biotechnology start-up with a novel precision platform developing breakthrough targeted eubiotics that improve the health and environmental impact of animals.
- DSM already owns 38.5% of the shares of Midori and has today acquired the remaining 61.5% for a consideration of US$63m.
- The eubiotics can reduce the environmental footprint of animal farming and support the accelerated replacement of antibiotics in animal feed.
- Midoris platform is highly synergetic with DSMs bioscience capability and current eubiotics portfolio, which was further strengthened through the acquisition of Biomin (as part of the Erber Group).
The major acquisitions and partnership by DSM in last three months we mention below:
Jan 2021: To address agricultural greenhouse gas emissions Fonterra and Royal DSM, a global science-based company, have signed a collaboration agreement. The agreement will helps to accelerate the transition to lower methane agriculture.
February 2020: Netherlands based Royal DSM announced an agreement to acquire Glycom A/S, the world’s leading supplier of Human Milk Oligosaccharides (HMO) for $826 million. With this deal DSM can accelerate the growth of Glycom by offering HMO products to DSMs global customer base and integrate it in its full solutions offering for Early Life Nutrition customers.
The acquisition by DSM can accelerate the HMO product development of Glycom by leveraging its strong R&D platform and clinical competencies to support Glycoms development of next generation HMOs. HMOs are a collection of carbohydrate structures found in human breast milk and its products are essential for both immune and cognitive development.
January 2020: Royal DSM, announced a new partnership with Generation Unlimited, a global partnership hosted by UNICEF that identifies and grows solutions to create employment opportunities for young people in agri-food businesses.
December 2019: Royal DSM, announced the completion of the acquisition of a 100% interest in specialty dairy solutions provider Koninklijke CSK Food Enrichment C.V. (Royal CSK) for approximately $165 million.
November 2019: Royal DSM, has acquired Boston based AVA, a personalized nutrition platform that provides nutrition and coaching recommendations across a wide range of health and wellness segments.
About Royal DSM
Royal DSM, headquartered at Heerlen, Netherlands, is a global science-based company in Nutrition, Health and Sustainable Living. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility & connectivity.